Alignment Healthcare, Inc. Stock Price, News & Analysis

Alignment Healthcare (NASDAQ: ALHC) has announced its participation in the Baird Global Healthcare Conference in New York. John Kao, founder and CEO, and Thomas Freeman, CFO, will present on Wednesday, Sept. 11, at 12:15 p.m. EDT.

This presentation offers investors and interested parties an opportunity to gain insights into Alignment Healthcare's strategies and performance. A webcast of the presentation will be available live, and a replay will be accessible afterwards on the company's investor relations website at https://ir.alignmenthealth.com/.

The Baird Global Healthcare Conference is a significant event in the healthcare industry, bringing together companies, investors, and analysts to discuss trends and opportunities in the sector.

Alignment Health's 2024 Social Threats to Aging Well in America survey reveals the top social barriers impacting U.S. seniors' health. The study, which surveyed over 2,000 seniors aged 65 or older, identified aging in place (69%), lack of transportation and access to medical care (64%), and economic insecurity (56%) as the primary challenges.

Key findings include:

• 22% of seniors experiencing stress ranked aging in place as their top stressor
• 67% would use benefits supporting aging in place if offered by their health plan
• 71% would use transportation benefits if available
• 26% of seniors admitted to skipping medical care, with 13% missing at least once in the past year
• 21% of seniors were unsure they had enough money to pay medical expenses in the next year

The survey also highlighted issues of lack of support (38%), mental health (33%), and loneliness (30%) as significant factors affecting seniors' health and wellness.

Alignment Healthcare (NASDAQ: ALHC) announced changes to its Board of Directors. Thomas (TJ) Carella and Jeffrey Margolis are stepping down effective immediately, with Margolis transitioning to an advisory role. Both directors have been praised for their contributions to the company's growth and vision. Carella, who joined in 2017, expressed confidence in Alignment's future impact. Margolis, a board member since 2014, highlighted CEO John Kao's leadership and the company's unique Medicare Advantage model. The resignations were not due to any disagreements with the company's operations or practices.

Alignment Healthcare (NASDAQ: ALHC) reported strong Q2 2024 results, with total revenue up 47.3% year-over-year to $681.3 million. The company saw exceptional Medicare Advantage membership growth of 56.1%, reaching approximately 175,100 members. Key financial highlights include:

- Adjusted gross profit: $76.8 million
- Loss from operations: $(18.4) million
- Medical benefits ratio: 88.7%
- Adjusted EBITDA: $6.0 million
- Net loss: $(24.0) million

Alignment Healthcare increased its year-end membership and revenue guidance while maintaining full-year adjusted gross profit and adjusted EBITDA guidance. The company's CEO, John Kao, expressed confidence in the firm's positioning for robust growth in 2025.

Alignment Healthcare's 3rd Annual ESG Report highlights significant achievements in improving senior health outcomes, enhancing care access, and reducing environmental impact. Key accomplishments include:

- 44% reduction in ER visits and 38% fewer inpatient admissions compared to 2019 Medicare FFS rates
- Expansion of affordable medication access, with 91% of pharmacy claims costing $10 or less
- 17% reduction in Scope 1 and 2 emissions from 2022 to 2023
- Hiring of 200+ bilingual concierge care navigators, reducing average call time by 50%

The report also details improvements in culturally tailored plans, employee benefits, and the company's proprietary technology platform AVA®. These efforts demonstrate Alignment's commitment to responsible service and community impact in the Medicare Advantage sector.

Alignment Healthcare (NASDAQ: ALHC) will announce its second quarter 2024 financial results on Thursday, Aug. 1, 2024, after market close. Following the release, the company will host a conference call to review the results at 5:30 p.m. EDT. The live audio webcast will be accessible online, with a replay available for about 12 months. This announcement is significant for investors and stakeholders interested in the financial performance of Alignment Healthcare, as it will provide insights into the company's earnings, revenue, and overall financial health for the quarter.

Alignment Healthcare announced that its Medicare Advantage HMO plans in North Carolina and Nevada have been recalculated to receive a 5-star rating by the Centers for Medicare and Medicaid Services (CMS) for 2024. This rating, the highest possible, reflects excellent performance in delivering high-quality care at lower costs. The improvement raises the contract's overall rating from 4.5 to 5 stars. More than 90% of Alignment's members are enrolled in plans rated 4 stars or higher, indicating consistent high-quality care. Alignment entered North Carolina in 2021 and earned a 5-star rating in the first year eligible, being one of only two MA HMO plans in the state to achieve this in 2023.

Alignment Healthcare (NASDAQ: ALHC) has announced that its founder and CEO, John Kao, along with CFO Thomas Freeman, will be presenting at William Blair's 44th Annual Growth Stock Conference in Chicago. The presentation is scheduled for June 5, 2024, at 12:40 p.m. CDT. Investors can access a live webcast and replay of the event on the company's investor relations website.

Alignment Healthcare, Inc. (NASDAQ: ALHC) reported strong first-quarter results with total revenue of $628.6 million, up 43.1% year-over-year. The company saw a 50.5% increase in Medicare Advantage membership to approximately 165,100 members. Adjusted gross profit was $57.3 million, while adjusted EBITDA was $(12.0) million. The outlook for the second quarter and fiscal year 2024 shows growth in health plan membership and revenues.